Skip to content
HowShorted

Precigen, Inc. short interest in 2024

In 2024, Precigen, Inc.'s disclosed short interest ran from 7.57% of shares outstanding on 12 Jan 2024 to 5.96% on 31 Dec 2024, a change of -1.61 percentage points. The year's high was 7.57% on 12 Jan 2024 and its low 5.09% on 15 Jul 2024, averaging 5.99% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.49 days on 31 Oct 2024. Full history: Precigen, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Precigen, Inc. in 2024

2024 in figures

Start of year
7.57% (12 Jan 2024)
End of year
5.96% (31 Dec 2024)
Change
-1.61 pp
High
7.57% (12 Jan 2024)
Low
5.09% (15 Jul 2024)
Average
5.99%
Highest days to cover
26.49 (31 Oct 2024)
SEC filings marked
9

Every report in 2024

Precigen, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20247.57%13.40
31 Jan 20247.52%16.90
15 Feb 20247.05%19.24
29 Feb 20246.94%13.11
15 Mar 20246.79%16.17
28 Mar 20246.79%15.8110-K filed, results (8-K)
15 Apr 20246.41%21.73
30 Apr 20246.03%21.97
15 May 20245.45%17.1310-Q filed, results (8-K)
31 May 20245.28%24.56
14 Jun 20245.17%9.22
28 Jun 20245.21%16.36
15 Jul 20245.09%17.34
31 Jul 20245.48%15.16
15 Aug 20245.19%6.83results (8-K), 10-Q filed, results (8-K)
30 Aug 20245.16%21.49
13 Sep 20245.69%15.17
30 Sep 20246.21%19.46
15 Oct 20246.08%22.54
31 Oct 20245.23%26.49
15 Nov 20245.52%16.6810-Q filed, results (8-K)
29 Nov 20245.79%19.44
13 Dec 20246.11%17.98
31 Dec 20245.96%7.92

See also: Precigen, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.